Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

GENELUX CORPORATION (GNLX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

GENELUX CORPORATION (GNLX), most recent 12 months reported: revenue $8K, net loss $35.6M, free cash flow -$28.68M. Latest balance sheet on file: liquid cash $18.67M. From SEC filings. Others in Pharmaceutical Preparations: JUPITER NEUROSCIENCES, INC. · Skinvisible, Inc. · PRF Technologies Ltd. · Aditxt, Inc. · Alaunos Therapeutics, Inc. · TALPHERA, INC. · AARDVARK THERAPEUTICS, INC. · ABVC BioPharma, Inc.

Stock screener

Watchlist